Mozz, I get it that you want to believe and you want to hope that there is a solution, but I find your hopium needs some reality check from time to time.
I am not sure where this forward sell of royalty 1st began getting airtime (was it @farmerbob?), but it has to stop.
Clearside, used actual collateral to secure that funding. What collateral you ask, well it was their 1st approved commercial product (Xipere). So 1 products sales revenues supports the development / study of another, all very normal, but PAR doesn't have any of that collateral.
The people at Healthcare Royalty have a due diligence process and part of that screening is NOT investing in a product that has not completed phase 3 development.
How do I know this? Well the good people at HCR were kind enough to give me 20 minutes of their time this morning for a conference call.
I will let you all know what the people at LaunchTx have to say about their process, post that call next week.
- Forums
- ASX - By Stock
- PAR
- How would involvement from a Venture capitalists or Private equity group look for Paradigm
How would involvement from a Venture capitalists or Private equity group look for Paradigm, page-43
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
25.0¢ |
Change
0.020(8.70%) |
Mkt cap ! $87.44M |
Open | High | Low | Value | Volume |
24.0¢ | 28.0¢ | 24.0¢ | $282.2K | 1.132M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4935 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.5¢ | 10408 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4935 | 0.250 |
5 | 130598 | 0.245 |
5 | 248929 | 0.240 |
4 | 174003 | 0.235 |
9 | 185224 | 0.230 |
Price($) | Vol. | No. |
---|---|---|
0.255 | 10408 | 2 |
0.260 | 47286 | 2 |
0.265 | 3846 | 1 |
0.270 | 18471 | 2 |
0.280 | 48587 | 4 |
Last trade - 13.46pm 20/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |